Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)

ApprovedCompleted

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Papulopustular Rosacea

Conditions

Papulopustular Rosacea

Trial Timeline

Feb 1, 2009 → Jul 1, 2009

NCT ID

NCT00855595

About Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)

Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea) is a approved stage product being developed by Bayer for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT00855595. Target conditions include Papulopustular Rosacea.

What happened to similar drugs?

2 of 12 similar drugs in Papulopustular Rosacea were approved

Approved (2) Terminated (1) Active (9)

🔄DFD-29 + Doxycycline + PlaceboDr. Reddy's LaboratoriesPhase 3

🔄Topical Dapsone 5% Gel + oral antibioticsBristol Myers SquibbPhase 3

✅Azelaic Acid foam 15%BayerApproved

✅azelaic acid 15% gel + azelaic acid 15% gelBayerApproved

🔄Azelaic acid foam, 15% (BAY39-6251) + Vehicle foamBayerPhase 3

❌S5G4T-1Sol-Gel TechnologiesPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT00855595	Approved	Completed	Feb 1, 2009	Jul 1, 2009	Papulopustular Rosacea

Competing Products

18 competing products in Papulopustular Rosacea

See all competitors

Product	Company	Stage	Hype Score
DFD-29 + Doxycycline + Placebo	Dr. Reddy's Laboratories	Phase 3	37
DFD-29 + Doxycycline + Placebo	Dr. Reddy's Laboratories	Phase 3	37
Lotilaner Gel, 2.0%	Tarsus Pharmaceuticals	Phase 2	29
Deucravacitinib + Placebo	Bristol Myers Squibb	Phase 2	27
Topical Dapsone 5% Gel + oral antibiotics	Bristol Myers Squibb	Phase 3	40
Azelaic Acid foam 15%	Bayer	Approved	40
Azelaic acid + Vehicle foam	Bayer	Phase 2	32
Azelaic acid foam 15% + Vehicle foam	Bayer	Phase 2	32
azelaic acid 15% gel + azelaic acid 15% gel	Bayer	Approved	40
Azelaic Acid Foam + Azelaic Acid Gel	Bayer	Phase 1	26
Azelaic acid foam, 15% (BAY39-6251) + Vehicle foam	Bayer	Phase 3	37
Encapsulated Benzoyl Peroxide Cream	Sol-Gel Technologies	Phase 1	19
S5G4T-1	Sol-Gel Technologies	Phase 3	22
S5G4T-1 + S5G4T-2	Sol-Gel Technologies	Phase 3	30
S5G4T-1 + S5G4T-2	Sol-Gel Technologies	Phase 3	30
FMX103 minocycline foam 1.5% + Vehicle foam	Vyne Therapeutics	Phase 3	30
FMX103 1.5%	Vyne Therapeutics	Phase 3	30
FMX103 minocycline foam 1.5% + Vehicle foam	Vyne Therapeutics	Phase 3	30